Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2026-05-02 @ 7:36 PM
Study NCT ID:
NCT02303769
Status:
COMPLETED
Last Update Posted:
2016-02-25
First Post:
2014-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS
Sponsor:
GL Pharm Tech Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GL2702-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None